Last edition
News about "clinical development "
Health Canada Grants Authorisation for Leqembi (Lecanemab)
BioArctic has the right to commercialise Leqembi in the Nordic region together with Eisai and the two companies are preparing for a joint commercialisation in the region.
Clinical Development | 28/10/2025 | By Dineshwori
Through a novel public-private partnership, IAVI, Minapharm and ProBioGen will work together to bolster the innovation ecosystem on the continent and enable sustainable access to urgently-needed products.
Clinical Development | 13/10/2025 | By Dineshwori
US FDA Grants Fast Track Designation to AAV Gene Therapy by Sanofi
The US FDA has granted fast track designation to Sanofi’s SAR446268, an AAV gene therapy for juvenile and adult-onset myotonic dystrophy type 1 (DM1).
Clinical Development | 23/09/2025 | By Dineshwori | 118
Alumis and Kaken Pharmaceutical to Develop ESK-001 in Dermatology in Japan
Under the terms of the agreement, Alumis will receive USD 40 million in upfront and near-term co-development payments from 2025 to 2026, with the potential to earn up to approximately USD 140 million in additional payments based on the achievement of milestones, and field option payments.
Clinical Development | 28/03/2025 | By Aishwarya | 281
Novartis to Acquire Anthos Therapeutics for USD 925 Million Upfront
Anthos Therapeutics, launched by Blackstone Life Sciences and Novartis in 2019, has advanced abelacimab through clinical development under a license from Novartis.
Clinical Development | 12/02/2025 | By Aishwarya | 254
Verismo Therapeutics Completes Merger to Accelerate Clinical Development
The merger will accelerate the clinical development of SynKIR™-110 and SynKIR™-310 for solid tumor and blood cancer patients, respectively, solidifying Verismo's and HLB Group's collective mission to advance its innovative KIR-CAR platform for patients worldwide.
Clinical Development | 21/12/2024 | By Aishwarya | 473
Allink Biotherapeutics Secures USD 42 Million Series A Financing Round
The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.
Clinical Development | 02/12/2024 | By Aishwarya | 169
BioMarin Strengthens its Leadership with New Appointments
At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.
Clinical Development | 22/08/2024 | By Aishwarya | 495
AusperBio Receives USD 37 Million in Series A Financing Round
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A financing round.
Clinical Development | 16/07/2024 | By Aishwarya | 505
Syngene Rolls Out New Platform for Enhanced Protein Production
Syngene International Ltd. has introduced its new protein production platform.
Clinical Development | 05/06/2024 | By Aishwarya | 593
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy